Growth hormone replacement therapy enhances humoral response to COVID-19 mRNA vaccination in patients with adult-onset growth hormone deficiency
Journal of Endocrinological Investigation · 2025
DOI: 10.1007/s40618-024-02528-7 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Journal of Endocrinological Investigation, 2025. Verfasst von Davide Masi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Experimental Medicine, Section of Medical Pathophysiology, Food Science and Endocrinology, Sapienza University of Rome, Viale Regina El…. Hauptthemen laut MEDLINE: COVID-19 Vaccines, Hormone Replacement Therapy, Human Growth Hormone, Immunity, Humoral. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 15 Literaturangaben.
Abstract (Originalsprache)
PURPOSE: Given the established link between GH/insulin-like growth factor 1 (IGF-1) deficiency and severe COVID-19 outcomes, this research seeks to determine whether GH therapy can enhance vaccine efficacy in patients with adult-onset growth hormone deficiency (aGHD). METHODS: We conducted an observational retrospective study involving two groups: a cohort of 10 patients (8 females, 2 males) with obesity and aGHD who initiated recombinant GH replacement therapy at a standard dose of 0.1 mg/day six months to one year before their first vaccine dose, and a matched control group of 7 patients (5 females, 2 males) with aGHD who had not started GH treatment. Both groups were matched for age, gender, and body mass index (BMI) to ensure comparability. Blood samples were collected 3 to 6 months after the third booster dose of the COVID-19 vaccine (BNT162b2, Pfizer-BioNTech) and analyzed for anti-SARS-CoV-2 antibodies using a commercially available assay. RESULTS: The GH-treated group exhibited a significantly greater humoral response compared to the untreated group, with a mean antibody titer of 19,122.1 ± 7,736.84 U/mL versus 9,539.14 ± 5,408.90 U/mL in the control group (p = 0.01). Multivariate regression analysis revealed that GH replacement therapy was the only statistically significant predictor of vaccine response, while factors such as male sex, age, and visceral adipose tissue showed negative correlations that did not reach significance. CONCLUSION: Our findings suggest that GH replacement therapy may enhance the immune response to COVID-19 vaccination in patients with aGHD, potentially improving their overall metabolic health and immune function.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Experimental Medicine, Section of Medical Pathophysiology, Food Science and Endocrinology, Sapienza University of Rome, Viale Regina Elena, 00161, Rome, Italy. davide.masi@uniroma1.it.
- Department of Experimental Medicine, Section of Medical Pathophysiology, Food Science and Endocrinology, Sapienza University of Rome, Viale Regina Elena, 00161, Rome, Italy.
- Department of Experimental Medicine, Section of Medical Pathophysiology, Food Science and Endocrinology, Sapienza University of Rome, Viale Regina Elena, 00161, Rome, Italy. carla.lubrano@uniroma1.it.
Zitieren
APA
Masi, D., Spoltore, M. E., Curreli, M., Costa, D., Gangitano, E., Mariani, S., Angeloni, A., Gnessi, L., Anastasi, E., & Lubrano, C. (2025). Growth hormone replacement therapy enhances humoral response to COVID-19 mRNA vaccination in patients with adult-onset growth hormone deficiency. Journal of Endocrinological Investigation. https://doi.org/10.1007/s40618-024-02528-7
Vancouver
Masi D, Spoltore ME, Curreli M, Costa D, Gangitano E, Mariani S, et al. Growth hormone replacement therapy enhances humoral response to COVID-19 mRNA vaccination in patients with adult-onset growth hormone deficiency. Journal of Endocrinological Investigation. 2025. doi:10.1007/s40618-024-02528-7
BibTeX
@article{Masi2025,
author = {Masi, Davide and Spoltore, Maria Elena and Curreli, Mariaignazia and Costa, Denise and Gangitano, Elena and Mariani, Stefania and Angeloni, Antonio and Gnessi, Lucio and Anastasi, Emanuela and Lubrano, Carla},
title = {Growth hormone replacement therapy enhances humoral response to COVID-19 mRNA vaccination in patients with adult-onset growth hormone deficiency},
journal = {Journal of Endocrinological Investigation},
year = {2025},
doi = {10.1007/s40618-024-02528-7}
}
EUVIMED